{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:49:56Z","timestamp":1791258596140,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1996,3,1]],"date-time":"1996-03-01T00:00:00Z","timestamp":825638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1996,3]]},"DOI":"10.1038\/nm0396-317","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T01:40:26Z","timestamp":1092879626000},"page":"317-322","source":"Crossref","is-referenced-by-count":526,"title":["Fas ligand in human serum"],"prefix":"10.1038","volume":"2","author":[{"given":"Masato","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyosuke","family":"Haze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Motoyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Mizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigetoshi","family":"Ohga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohiko","family":"Hatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan H.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigekazu","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm0396317_CR1","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood.V85.12.3378.bloodjournal85123378","volume":"85","author":"H-J Gruss","year":"1995","unstructured":"Gruss, H.-J. & Dower, S. Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphoma. Blood 85, 3378\u20133404 (1995).","journal-title":"Blood"},{"key":"BFnm0396317_CR2","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1126\/science.7533326","volume":"267","author":"S Nagata","year":"1995","unstructured":"Nagata, S. & Golstein, P. The Fas death factor. Science 267, 1449\u20131456 (1995).","journal-title":"Science"},{"key":"BFnm0396317_CR3","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/0092-8674(93)90326-L","volume":"75","author":"T Suda","year":"1993","unstructured":"Suda, T., Takahashi, T., Golstein, P. & Nagata, S. Molecular cloning and expression of the Fas ligand: A novel member of the tumor necrosis factor family. Cell 75, 1169\u20131178 (1993).","journal-title":"Cell"},{"key":"BFnm0396317_CR4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0092-8674(94)90372-7","volume":"76","author":"CA Smith","year":"1994","unstructured":"Smith, C.A., Farrah, T. & Goodwin, R.G. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76, 959\u2013962 (1994).","journal-title":"Cell"},{"key":"BFnm0396317_CR5","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.4049\/jimmunol.154.8.3806","volume":"154","author":"T Suda","year":"1995","unstructured":"Suda, T. et al. Expression of the Fas ligand in T-cell-lineage. J. Immunol. 154, 3806\u20133813 (1995).","journal-title":"J. Immunol."},{"key":"BFnm0396317_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.181.2.781","volume":"181","author":"F Vignaux","year":"1995","unstructured":"Vignaux, F. et al. TCR\/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181, 781\u2013786 (1995).","journal-title":"J. Exp. Med."},{"key":"BFnm0396317_CR7","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.148.4.1274","volume":"148","author":"R Watanabe-Fukunaga","year":"1992","unstructured":"Watanabe-Fukunaga, R. et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274\u20131279 (1992).","journal-title":"J. Immunol."},{"key":"BFnm0396317_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/ng1195-294","volume":"11","author":"M Adachi","year":"1995","unstructured":"Adachi, M. et al. Targeted mutation in the Fas gene causes hyperplasia in the peripheral lymphoid organs and liver. Nature Genet. 11, 294\u2013300 (1995).","journal-title":"Nature Genet."},{"key":"BFnm0396317_CR9","doi-asserted-by":"crossref","unstructured":"Adachi, M. et al. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA (in the press).","DOI":"10.1073\/pnas.93.5.2131"},{"key":"BFnm0396317_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0167-5699(95)80069-7","volume":"16","author":"S Nagata","year":"1995","unstructured":"Nagata, S. & Suda, T. Fas and Fas ligand: Ipr and gld mutations. Immunol. Today 16, 39\u201343 (1995).","journal-title":"Immunol. Today"},{"key":"BFnm0396317_CR11","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","volume":"270","author":"T Griffith","year":"1995","unstructured":"Griffith, T., Brunner, T., Fletcher, S., Green, D. & Ferguson, T. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189\u20131192 (1995).","journal-title":"Science"},{"key":"BFnm0396317_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/377630a0","volume":"377","author":"D Bellgrau","year":"1995","unstructured":"Bellgrau, D. et al. A role for CD9S ligand in preventing graft rejection. Nature 377, 630\u2013632 (1995).","journal-title":"Nature"},{"key":"BFnm0396317_CR13","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","volume":"81","author":"GH Fisher","year":"1995","unstructured":"Fisher, G.H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935\u2013946 (1995).","journal-title":"Cell"},{"key":"BFnm0396317_CR14","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1126\/science.7539157","volume":"268","author":"F Rieux-Laucat","year":"1995","unstructured":"Rieux-Laucat, F. et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347\u20131349 (1995).","journal-title":"Science"},{"key":"BFnm0396317_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","volume":"76","author":"T Takahashi","year":"1994","unstructured":"Takahashi, T. et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969\u2013976 (1994).","journal-title":"Cell"},{"issue":"6367","key":"BFnm0396317_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/356314a0","volume":"356","author":"Rie Watanabe-Fukunaga","year":"1992","unstructured":"Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., Sc Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314\u2013317 (1992).","journal-title":"Nature"},{"key":"BFnm0396317_CR17","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/hep.1840190606","volume":"19","author":"N Hiramatsu","year":"1994","unstructured":"Hiramatsu, N. et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19, 1354\u20131359 (1994).","journal-title":"Hepatology"},{"key":"BFnm0396317_CR18","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood.V83.10.3101a.3101a","volume":"83","author":"K-M Debatin","year":"1994","unstructured":"Debatin, K.-M. et al. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 83, 3101\u20133103 (1994).","journal-title":"Blood"},{"key":"BFnm0396317_CR19","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1084\/jem.181.6.2029","volume":"181","author":"P Katsikis","year":"1995","unstructured":"Katsikis, P., Wunderlich, E., Smith, C., Herzenberg, L. & Herzenberg, L. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181, 2029\u20132036 (1995).","journal-title":"J. Exp. Med."},{"key":"BFnm0396317_CR20","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood.V79.12.3300.bloodjournal79123300","volume":"79","author":"MH Falk","year":"1992","unstructured":"Falk, M.H. et al. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 79, 3300\u20133306 (1992).","journal-title":"Blood"},{"key":"BFnm0396317_CR21","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/364806a0","volume":"364","author":"J Ogasawara","year":"1993","unstructured":"Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806\u2013809 (1993).","journal-title":"Nature"},{"key":"BFnm0396317_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0014-5793(91)80803-B","volume":"285","author":"W Fiers","year":"1991","unstructured":"Fiers, W. Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level. FEBS Lett. 285, 199\u2013212 (1991).","journal-title":"FEBS Lett."},{"key":"BFnm0396317_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev.iy.10.040192.002211","volume":"10","author":"P Vassalli","year":"1992","unstructured":"Vassalli, P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10, 411\u2013452 (1992).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnm0396317_CR24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/370218a0","volume":"370","author":"KM Mohler","year":"1994","unstructured":"Mohler, K.M. et al. Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature 370, 218\u2013220 (1994).","journal-title":"Nature"},{"issue":"6490","key":"BFnm0396317_CR25","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/370558a0","volume":"370","author":"Gerard M. McGeehan","year":"1994","unstructured":"McGeehan, G.M. et al. Regulation of tumor necrosis factor-a processing by a metal-loproteinase inhibitor. Nature 370, 558\u2013561 (1994).","journal-title":"Nature"},{"issue":"6490","key":"BFnm0396317_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/370555a0","volume":"370","author":"A. J. H. Gearing","year":"1994","unstructured":"Gearing, A.J.H. et al. Processing of tumor necrosis factor-a precursor by metallopro-teinases. Nature 370, 555\u2013557 (1994).","journal-title":"Nature"},{"key":"BFnm0396317_CR27","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/320584a0","volume":"320","author":"B Beutler","year":"1986","unstructured":"Beutler, B. & Cerami, A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 320, 584\u2013588 (1986).","journal-title":"Nature"},{"key":"BFnm0396317_CR28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/j.1460-2075.1995.tb07096.x","volume":"14","author":"M Tanaka","year":"1995","unstructured":"Tanaka, M., Suda, T., Takahashi, T. & Nagata, S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14, 1129\u20131135 (1995).","journal-title":"EMBO J."},{"key":"BFnm0396317_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V82.1.1.bloodjournal8211","volume":"82","author":"TP Loughran","year":"1993","unstructured":"Loughran, T.P., Clonal diseases of large granular lymphocytes. Blood 82, 1\u201314 (1993).","journal-title":"Blood"},{"key":"BFnm0396317_CR30","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1093\/intimm\/6.10.1567","volume":"6","author":"T Takahashi","year":"1994","unstructured":"Takahashi, T. et al. Human Fas ligand: Gene structure, chromosomal location and species specificity. Int. Immunol. 6, 1567\u20131574 (1994).","journal-title":"Int. Immunol."},{"key":"BFnm0396317_CR31","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1084\/jem.179.3.873","volume":"179","author":"T Suda","year":"1994","unstructured":"Suda, T. & Nagata, S. Purification and characterization of the Fas ligand that induces apoptosis. J. Exp. Med. 179, 873\u2013878 (1994).","journal-title":"J. Exp. Med."},{"key":"BFnm0396317_CR32","first-page":"465","volume":"6","author":"S Tagawa","year":"1992","unstructured":"Tagawa, S. et al. Transformation of large granular lymphocytic leukemia during the course of a reactive human herpesvirus-6 infection. Leukemia 6, 465\u2013469 (1992).","journal-title":"Leukemia"},{"key":"BFnm0396317_CR33","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1182\/blood.V71.4.1161.1161","volume":"71","author":"S Tagawa","year":"1988","unstructured":"Tagawa, S., Hatakeyama, M., Shibano, M., Taniguchi, T. & Kitani, T. The expression of the p75 subunit of interleukin 2 receptor in Tac negative leukemic cells of two patients with large granular lymphocytic leukemia. Blood 71, 1161\u20131164 (1988).","journal-title":"Blood"},{"key":"BFnm0396317_CR34","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1126\/science.7518614","volume":"265","author":"D Kagi","year":"1994","unstructured":"Kagi, D. et al. Fas and perform pathway as major mechanisms of T cell-mediated cvtotoxicity. Science 265, 528\u2013530 (1994).","journal-title":"Science"},{"key":"BFnm0396317_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/1074-7613(94)90066-3","volume":"1","author":"H Kojima","year":"1994","unstructured":"Kojima, H. et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1, 357\u2013364 (1994).","journal-title":"Immunity"},{"key":"BFnm0396317_CR36","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/370650a0","volume":"370","author":"B Lowin","year":"1994","unstructured":"Lowin, B., Hahne, M., Mattmann, C. & Tschopp, J., T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370, 650\u2013652 (1994).","journal-title":"Nature"},{"key":"BFnm0396317_CR37","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.4049\/jimmunol.153.9.3938","volume":"153","author":"T Kataoka","year":"1994","unstructured":"Kataoka, T. et al. Acidification is essential for maintaining the structure and function of lytic granules of CTL. J. Immunol. 153, 3938\u20133947 (1994).","journal-title":"J. Immunol."},{"key":"BFnm0396317_CR38","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1084\/jem.175.3.789","volume":"175","author":"J Chehimi","year":"1992","unstructured":"Chehimi, J. et al. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175, 789\u2013796 (1992).","journal-title":"J. Exp. Med."},{"key":"BFnm0396317_CR39","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood.V84.4.1201.1201","volume":"84","author":"K Iwai","year":"1994","unstructured":"Iwai, K. et al. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84, 1201\u20131208 (1994).","journal-title":"Blood"},{"key":"BFnm0396317_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/369031a0","volume":"369","author":"D Kagi","year":"1994","unstructured":"Kagi, D. et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31\u201337 (1994).","journal-title":"Nature"},{"key":"BFnm0396317_CR41","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1084\/jem.181.3.1235","volume":"181","author":"H Arase","year":"1995","unstructured":"Arase, H., Arase, N. & Saito, T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181, 1235\u20131238 (1995).","journal-title":"J. Exp. Med."},{"key":"BFnm0396317_CR42","first-page":"415","volume":"69","author":"F Leithauser","year":"1993","unstructured":"Leithauser, F. et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor\/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69, 415\u2013429 (1993).","journal-title":"Lab. Invest."},{"key":"BFnm0396317_CR43","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/00002371-199310000-00011","volume":"14","author":"LB Owen-Schaub","year":"1993","unstructured":"Owen-Schaub, L.B., Meterissian, S. & Ford, R.J. Fas\/APO-1 expression and function on malignant cells of hematologic and nonhematologic origin. J. Immunother. 14, 234\u2013241 (1993).","journal-title":"J. Immunother."},{"issue":"6554","key":"BFnm0396317_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/378245a0","volume":"378","author":"Jenny E. Gumperz","year":"1995","unstructured":"Gumperz, J.E. & Parham, P. The enigma of the natural killer cell. Nature 378, 245\u2013248 (1995).","journal-title":"Nature"},{"key":"BFnm0396317_CR45","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1073\/pnas.92.8.3081","volume":"92","author":"W Yokoyama","year":"1995","unstructured":"Yokoyama, W. Natural killer cell receptors specific for major rustocompatibility complex class I molecule. Proc. Natl. Acad. Sci. USA 92, 3081\u20133085 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0396317_CR46","first-page":"9","volume":"2","author":"J Ameisen","year":"1995","unstructured":"Ameisen, J., Estaquier, J., Idziorek, T. & De Bels, F. Programmed cell death and AIDS: Significance, perspective and unanswered questions. Cell Death Differ. 2, 9\u201322 (1995).","journal-title":"Cell Death Differ."},{"key":"BFnm0396317_CR47","first-page":"1","volume":"2","author":"M Gougeon","year":"1995","unstructured":"Gougeon, M. Does apoptosis contribute to CD4 T cell depletion in human immunodeficiency virus infection? Cell Death Differ. 2, 1\u20138 (1995).","journal-title":"Cell Death Differ."},{"key":"BFnm0396317_CR48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/375078a0","volume":"375","author":"M Enari","year":"1995","unstructured":"Enari, M., Hug, H. & Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375, 78\u201381 (1995).","journal-title":"Nature"},{"key":"BFnm0396317_CR49","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0378-1119(91)90152-2","volume":"105","author":"JJ Clare","year":"1991","unstructured":"Clare, J.J. et al. Production of mouse epidermal growth factor in yeast: High-level secretion using Pichia pastoris strains containing multiple gene copies. Gene 105, 205\u2013212 (1991).","journal-title":"Gene"},{"issue":"17","key":"BFnm0396317_CR50","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1093\/nar\/18.17.5322","volume":"18","author":"Seiichi Mizushima","year":"1990","unstructured":"Mizushima, S. & Nagata, S. pEF-BOS: A powerful mammalian expression vector. Nucleic Acids Res. 18, 5322 (1990).","journal-title":"Nucleic Acids Research"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0396-317","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0396-317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0396-317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:11:06Z","timestamp":1684447866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0396-317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,3]]}},"alternative-id":["BFnm0396317"],"URL":"https:\/\/doi.org\/10.1038\/nm0396-317","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,3]]}}}